Lanoxin and Questran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanoxin (digoxin) and Questran (cholestyramine). Common drug interactions include pericarditis among females and cholelithiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Lanoxin and Questran. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Questran?

Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.

On Jul, 29, 2026

50 people who take Lanoxin and Questran together, and have interactions are studied.

What are the common drug interactions of Lanoxin and Questran, by gender? *:

female:

Pericarditis (inflammation of the pericardium)
Tracheitis (an inflammation of the trachea)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Dehydration (dryness resulting from the removal of water)
Drug ineffective
Ileus (a painful obstruction of the ileum or other part of the intestine)
Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Anxiety
Blood chloride decreased

male:

Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Weight decreased
Anxiety
Constipation
Foot ulcer
Hepatocellular damage (liver damage)
Hypokalaemia (low potassium)
Injury
Osteomyelitis (infection of bone)
Renal failure (kidney dysfunction)

What are the common drug interactions of Lanoxin and Questran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cholecystitis acute (rapid infection of gallbladder)
Abdominal pain
Tracheitis (an inflammation of the trachea)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Dehydration (dryness resulting from the removal of water)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood chloride decreased
Chest pain
Dehydration (dryness resulting from the removal of water)
Hypokalaemia (low potassium)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypotension (abnormally low blood pressure)
Nausea (feeling of having an urge to vomit)
Pneumonia
Retching (strong involuntary effort to vomit)
Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

Blood in stool
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Chest pain
Cholecystitis (infection of gallbladder)
Cholecystitis acute (rapid infection of gallbladder)
Chronic obstructive airways disease
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Cyst (a closed sac)
Dehydration (dryness resulting from the removal of water)

60+:

Weight decreased
Myalgia (muscle pain)
Hepatocellular damage (liver damage)
Hypokalaemia (low potassium)
Osteomyelitis (infection of bone)
Pain
Skin amp subcutaneous tissue abscess (infection of the skin and subcutaneous tissue)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Weakness
Abdominal pain

What are the existing conditions these people have? *

Pain: 4 people, 8.00%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 6.00%
Diabetes: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and Questran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously